Tesamorelin 11.8mg — Certificate of Analysis

Name: Certificate of Analysis — Tesamorelin 11.8mg — Lot DRL-06-TESA10
Creator: Kovera Labs
Published: 2026-05-22
License: https://vialtalk.com/coa-scoring
Keywords: Tesamorelin 11.8mg, peptide COA, third-party lab testing, Kovera Labs, purity verification

From Double R Labs · Lot DRL-06-TESA10 · Tested 5/22/2026

← Back to Double R Labs

COA Document

View on lab portal

Live from Kovera Labs's verification portalVerify at source

Measurement Breakdown

Sub-scores compose the VialTalk methodology grade. Methodology →

PurityFull credit

Reported purity 99.72% via hplc

IdentityFull credit

Identity confirmed via mass spec

Weight AccuracyFull credit

Tested 9.96mg vs 11.8mg labeled

EndotoxinFull credit

Tested via usp 85 compendial

Heavy MetalsFull credit

Tested via icp ms

SterilityFull credit

Tested via usp 71 compendial

Batch ConformityStrong

Conformity shape: three four batch avg per vial

Composite quality score

108.7(v2)

Grade

A++

Superlative

Scores above 100 reflect lab credibility bonuses.

Tests performed

Mass SpecEndotoxinHeavy MetalsSterilityBatch ConformityFentanyl Screen* not scored

Laboratory

Kovera Labs

Third-partyFentanyl Tested

Method: HPLC

Reported purity: 99.72%

Weight: 11.8mg labeled → 9.96mg tested

Visit Double R Labs website View vendor profile Report this COA / question this result